Skip to main content
Log in

Greater OOP costs with Medicare prescription drug plans

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. preferred generics with lowest cost sharing

  2. brand-name drugs, specialty drugs and nonpreferred generics

Reference

  • Liu P, et al. Medicare Beneficiary Out-of-Pocket Costs for Generic Cardiovascular Medications Available Through $4 Generic Drug Discount Programs. Annals of Internal Medicine : 24 Jul 2018. Available from: URL: http://dx.doi.org/10.7326/M18-0965

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Greater OOP costs with Medicare prescription drug plans. PharmacoEcon Outcomes News 809, 20 (2018). https://doi.org/10.1007/s40274-018-5172-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5172-z

Navigation